March 20, 2010
PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B clinical study to evaluate the safety and efficacy of PMX-60056 in reversing the anticoagulant activity of low molecule weight heparin (LMWH). In a previously conducted Phase 1B, PMX-60056 demonstrated safety and efficacy in reversing heparin in healthy subjects. PMX-60056, one of PolyMedix’s lead compounds, is designed as a small synthetic molecule to reverse heparin-induced anticoagulation…
Go to Source… Continue reading
March 20, 2010
Authors: Kim WC, Lee CH
Ribonucleases (RNases) are a group of enzymes that cleave RNAs at phosphodiester bonds resulting in remarkably diverse biological consequences. This review focuses on mammalian RNases that are capable of, or potentially capable of, cleaving messenger RNA (mRNA) as well as other RNAs in cells and play roles in the development of human cancers. The aims of this review are to provide an overview of the roles of currently known mammalian RNases, and the evidence that associate them as regulators of tumor development. The roles of these RNases as oncoproteins and/or tumor suppressors in influencing cell… Continue reading
March 20, 2010
In a study of Japanese schoolchildren, vitamin D supplements taken during the winter and early spring helped prevent seasonal flu and asthma attacks.
The idea for the study, study chief Dr. Mitsuyoshi Urashima, told Reuters Health, came from an earlier study looking at whether vitamin D could help prevent the bone-thinning disease osteoporosis. The researchers in that study noticed that people taking vitamin D were three times less likely to report cold and flu symptoms.
This led Urashima, of Jikei University School of Medicine, Tokyo, and colleagues to randomly assign a group of 6- to 15-year-old children to take vitamin D3 supplements… Continue reading
March 19, 2010
The American College of Physicians, representing 129,000 internal medicine physician and medical student members, said that Congress should cast the final votes needed to get comprehensive health care reform enacted into law. Without reform, ACP said, tens of millions of Americans stand to lose access to affordable health care and out-of-control spending will trigger an unprecedented fiscal and budgetary crisis. ACP said that H.R…
Go to Source… Continue reading
March 19, 2010
This video highlights President Obama’s remarks during a health care reform rally held Friday, at George Mason University.
Related: Transcript: President Obama’s Health Reform Rally Remarks
Go to Source… Continue reading
